Connect Biopharma is trading 7.7% higher at $0.94 before the market opens on October 12, with the reason for the rise unclear. - The October 9 closing price was $0.87. - No new company-specific announcement explaining the move appeared in available search results. Positive COPD trial news dates to September 30 and is not a confirmed fresh catalyst. - Broader market indicators are mixed; biotech-sector coverage reports XBI down 0.4%, so a sector rally cannot be confirmed as the cause.